SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ranbaxy Laboratories comes into black for Q1CY12

09 May 2012 Evaluate

Drug maker Ranbaxy Laboratories has reported higher than expected profit for the quarter ended March 31, 2012.

The company has posted a net profit of Rs 827.23 crore for Q1CY12 as compared to net loss of Rs 52.90 crore for the Q1CY11. The company’s total income has increased by 72.26% to Rs 2050.11 crore for the quarter as compared to Rs 1190.14 crore for the similar quarter of previous fiscal.

On consolidated basis, group’s net profit after tax, minority interest and share of profit of associates zoomed by 309.59% at Rs 1246.76 crore for the January-March quarter as compared to Rs 304.39 crore for the similar quarter a period ago. Group’s total income has risen by 71.84% to Rs 3923.47 crore for the quarter under review from Rs 2283.19 crore for the quarter ended March 31, 2011. The estimates were that the group would report a growth of 34% year-on-year in its profit after tax at Rs 408 crore for the first quarter of CY12.

As of March 2012, Ranbaxy had 45% market share in the Lipitor generic market. In Q4, Lipitor generic contributed USD 300 million to revenues and market share was 42% with price erosion of 65%.

Peers
Company Name CMP
Sun Pharma Inds. 1871.70
Dr. Reddys Labs. 1327.25
Cipla 1437.35
Zydus Lifesciences 1096.00
Lupin 2371.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: